Skip to main content
Clinical Trials/NCT04958668
NCT04958668
Completed
Not Applicable

Prospective Evaluation of Volatile Sedation With Regard to Awakening Behaviour and Extubation Capacity in Patients Undergoing Heart Valve Surgery

Goethe University1 site in 1 country100 target enrollmentNovember 1, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Valve Heart Disease
Sponsor
Goethe University
Enrollment
100
Locations
1
Primary Endpoint
Time to extubation
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

Cardiac surgery is a complex operative procedure with a substantial risk of postoperative complications, so that patients undergoing valve surgery are usually transferred to the intensive care unit postoperatively. Various substances are used to maintain the required sedation, such as volatile anaesthetics and intravenous sedatives combined with analgetic therapy using opioids.

The study intends to investigate to what extent the already well-described effect of volatile anaesthetics on recovery can be realised despite the need for differentiated intensive care and medical management.

Registry
clinicaltrials.gov
Start Date
November 1, 2021
End Date
December 1, 2023
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Goethe University
Responsible Party
Principal Investigator
Principal Investigator

Armin N. Flinspach

Principal Investigator

Goethe University

Eligibility Criteria

Inclusion Criteria

  • Valve reconstruction or valve replacement
  • Must be capable to giving written consent

Exclusion Criteria

  • Intolerance to volatile anaesthetics (e.g. malignant hyperthermia)
  • Severe obstructive pulmonary disease
  • Extended aortic arch or ascending aorta surgery
  • Age \<18 years

Outcomes

Primary Outcomes

Time to extubation

Time Frame: through study completion, an average of 2 days

Time from admission on ICU until awakening and Extubation.

Secondary Outcomes

  • Factors related to the course of operative procedure(through study completion, up to 24 hours)
  • Factor related to the course of intensive care: kidney injury(through study completion, an average of 24 hours)
  • Factor related to the course of intensive care: blood loss(through study completion, an average of 24 hours)
  • Factor related to the course of intensive care: acid-base balance(through study completion, an average of 24 hours)
  • Factor related to the course of intensive care: lung function parameters(through study completion, an average of 24 hours)
  • Factor related to the course of intensive care:cardiovascular medication(through study completion, an average of 24 hours)
  • Time to neurocognitive assessability(through study completion, an average of 2 days)
  • Required setup time of the intensive care workplace(through study completion, up to 24 hours)
  • Intra-hospital mortality(through study completion, an average of 7 days)
  • Liver failure(through study completion, an average of 7 days)
  • postoperative nausea and vomiting(through study completion, up to 24 hours)

Study Sites (1)

Loading locations...

Similar Trials